Mark Velleca | CEO |
Buck Phillips | CFO |
Raj Malik | SVP & Chief Medical Officer |
Terry Murdock | SVP, Development Operations |
Jeff Macdonald | IR |
Tessa Romero | J.P. Morgan |
Joseph Thome | Cowen & Company |
Dane Leone | BTIG |
Chad Messer | Needham & Company |
Good day, ladies and gentlemen, and welcome to the G1 Therapeutics First Quarter 2018 Corporate and Financial Update. [Operator Instructions)].
As a reminder, today's program may be recorded. I would now like introduce your today's program, Jeff Macdonald. Sir, you may begin.